Eugenie Pedagogos

300 Grattan Street
Parkville, VIC 3050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease.

Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Published: March 24, 2021

Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.

Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.

Journal: The Journal of antimicrobial chemotherapy

Published: April 20, 2018

Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.

Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.

Journal: International journal of antimicrobial agents

Published: September 15, 2017

Should nephrologists consider vascular calcification screening?

Should nephrologists consider vascular calcification screening?

Journal: Nephrology (Carlton, Vic.)

Published: April 22, 2017

Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.

Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.

Journal: Kidney & blood pressure research

Published: February 03, 2017

Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study.

Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study.

Journal: BMC nephrology

Published: December 05, 2016

Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Journal: Nephrology (Carlton, Vic.)

Published: March 13, 2016

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

Journal: Redox report : communications in free radical research

Published: June 18, 2015

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Journal: Canadian journal of kidney health and disease

Published: May 17, 2015

Calcific uraemic arteriolopathy in a patient with end-stage renal failure and chronic plaque psoriasis: could TNF-α inhibition help ameliorate disease progression?

Calcific uraemic arteriolopathy in a patient with end-stage renal failure and chronic plaque psoriasis: could TNF-α inhibition help ameliorate disease progression?

Journal: The Australasian journal of dermatology

Published: February 18, 2015

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: February 17, 2014

Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure.

Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure.

Journal: Nephrology (Carlton, Vic.)

Published: November 25, 2012

Showing 1-12 of 17

Last Updated: 09/26/2026